The Community Guide

- gsearch

Search Results

Narrow Results:

Journal Article 49
Journal Issue 1

Statistics 1

1 - 20 of 50 Results

Refine Results

Refine Results:

High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique

CITE Title : High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique Personal Author(s) : Semá Baltazar, Cynthia;Horth, Roberta;Boothe, Makini;Sathane, Isabel;Young, Peter;Chitsondzo Langa, Denise;Condula, Manuel;Ricardo, Helena;Dengo Baloi, Liliana;Cummings, Beverley;Schaad, Nicolas;Gouveia, Lídia;Teodoro, Eugénia;Raymond, Henry F.; Published Date : December 02 2019 Source : BMC Infect Dis. 19 URL : https://stacks.cdc.gov/view/cdc/84225 Semá Baltazar, Cynthia et al. (2019). High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique. 19 Semá Baltazar, Cynthia et al. "High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique" 19 (2019) Semá Baltazar, Cynthia et al. "High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique" vol. 19, 2019 Export RIS Citation Information.

:

Semá Baltazar, Cynthia ;

Horth, Roberta

December 02 2019 | BMC Infect Dis. 19

:

BackgroundFew countries in sub-Saharan Africa know the magnitude of their HIV epidemic among people who inject drugs (PWID). This was the first study ...
Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients.

CITE Title : Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients. Personal Author(s) : Oberle, Mark W.;Shapiro, Craig N.;Lanier, Anne P.; Published Date : 1997 Jan-Feb Source : Public Health Rep. 112(1):63-65 URL : https://stacks.cdc.gov/view/cdc/64504 Oberle, Mark W. et al. (1997). Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients.. 112(1). Oberle, Mark W. and Shapiro, Craig N. and Lanier, Anne P. "Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients." 112, no. 1 (1997) Oberle, Mark W. et al. "Preventing hepatitis B in people in close contact with hepatocellular carcinoma patients." vol. 112, no. 1, 1997 Export RIS Citation Information.

:

Oberle, Mark W. ;

Shapiro, Craig N.

1997 Jan-Feb | Public Health Rep. 112(1):63-65

:

To determine the prevalence of testing for hepatitis B virus (HBV) infection in the clinical management of primary liver cancer (hepatocellular carcin...
The hepatitis B virus.

CITE Title : The hepatitis B virus. Personal Author(s) : Blumberg, B S Published Date : 1980 Sep-Oct;Sep-Oct 1980; Source : Public Health Rep. 95(5):427-435 URL : https://stacks.cdc.gov/view/cdc/65683 Blumberg, B S (1980). The hepatitis B virus.. 95(5). Blumberg, B S "The hepatitis B virus." 95, no. 5 (1980) Blumberg, B S "The hepatitis B virus." vol. 95, no. 5, 1980 Export RIS Citation Information.

:

Blumberg, B S

1980 Sep-Oct | Public Health Rep. 95(5):427-435

No Description
Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.

CITE Title : Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons. Personal Author(s) : McMillan, B C;Hanson, R P;Golubjatnikov, R;Sinha, S K; Published Date : Jun 1979;6-1979; Source : Public Health Rep. 94(3):262-267 URL : https://stacks.cdc.gov/view/cdc/65540 McMillan, B C et al. (1979). Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons.. 94(3). McMillan, B C et al. "Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons." 94, no. 3 (1979) McMillan, B C et al. "Hepatitis-B surface antigen and antibody: prevalence and persistence in institutionalized and noninstitutionalized persons." vol. 94, no. 3, 1979 Export RIS Citation Information.

:

McMillan, B C ;

Hanson, R P

Jun 1979 | Public Health Rep. 94(3):262-267

:

A total of 426 persons were studied in an attempt to more clearly define the high prevalence of hepatitis-B surface antigen (HBsAg) seen among institu...
The status of hepatitis B control in the African region

CITE Title : The status of hepatitis B control in the African region Personal Author(s) : Breakwell, Lucy;Tevi-Benissan, Carol;Childs, Lana;Mihigo, Richard;Tohme, Rania; Published Date : June 22 2017 Source : Pan Afr Med J. 2017; 27(Suppl 3) URL : https://stacks.cdc.gov/view/cdc/95582 Breakwell, Lucy et al. (2017). The status of hepatitis B control in the African region. 27 Breakwell, Lucy et al. "The status of hepatitis B control in the African region" 27 (2017) Breakwell, Lucy et al. "The status of hepatitis B control in the African region" vol. 27, 2017 Export RIS Citation Information.

:

Breakwell, Lucy ;

Tevi-Benissan, Carol

June 22 2017 | Pan Afr Med J. 2017; 27(Suppl 3)

:

The World Health Organization (WHO) African Region has approximately 100 million people with chronic hepatitis B virus (HBV) infection. This review de...
Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria

CITE Title : Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria Personal Author(s) : Adekunle, Ajayi Ebenezer;Oladimeji, Ajayi Akande;Temi, Adegun Patrick;Adeseye, Ajayi Iyiade;Akinyeye, Ojo Abiodun;Taiwo, Raimi Hussean; Published Date : May 21 2011 Source : Pan Afr Med J. 2011; 9. URL : https://stacks.cdc.gov/view/cdc/22790 Adekunle, Ajayi Ebenezer et al. (2011). Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria. 9 Adekunle, Ajayi Ebenezer et al. "Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria" 9 (2011) Adekunle, Ajayi Ebenezer et al. "Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria" vol. 9, 2011 Export RIS Citation Information.

:

Adekunle, Ajayi Ebenezer ;

Oladimeji, Ajayi Akande

May 21 2011 | Pan Afr Med J. 2011; 9.

:

BackgroundEkiti State of Nigeria is known to have the lowest prevalence of HIV in Nigeria. University Teaching Hospital (UTH), Ado Ekiti was recently ...
Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility—Virginia, 2010

CITE Title : Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility—Virginia, 2010 Personal Author(s) : Bender, Thomas John;Sharapov, Umid;Utah, Okey;Xing, Jian;Hu, Dale;Rybczynska, Jolanta;Drobeniuc, Jan;Kamili, Saleem;Spradling, Philip R.;Moorman, Anne C.; Published Date : 2 07 2014;2-07-; Source : Vaccine. 32(7):852-856 URL : https://stacks.cdc.gov/view/cdc/50496 Bender, Thomas John et al. (2014). Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility—Virginia, 2010. 32(7). Bender, Thomas John et al. "Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility—Virginia, 2010" 32, no. 7 (2014) Bender, Thomas John et al. "Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility—Virginia, 2010" vol. 32, no. 7, 2014 Export RIS Citation Information.

:

Bender, Thomas John ;

Sharapov, Umid

2 07 2014 | Vaccine. 32(7):852-856

:

BackgroundFailure to adhere to infection control guidelines, especially during assisted monitoring of blood glucose, has caused multiple hepatitis B o...
Cost-Effectiveness of Testing Hepatitis B–Positive Pregnant Women for Hepatitis B e Antigen or Viral Load

CITE Title : Cost-Effectiveness of Testing Hepatitis B–Positive Pregnant Women for Hepatitis B e Antigen or Viral Load Personal Author(s) : Fan, Lin;Owusu-Edusei, Kwame;Schillie, Sarah F.;Murphy, Trudy V.; Published Date : 5 2014;5-2014; Source : Obstet Gynecol. 123(5):929-937 URL : https://stacks.cdc.gov/view/cdc/36897 Fan, Lin et al. (2014). Cost-Effectiveness of Testing Hepatitis B–Positive Pregnant Women for Hepatitis B e Antigen or Viral Load. 123(5). Fan, Lin et al. "Cost-Effectiveness of Testing Hepatitis B–Positive Pregnant Women for Hepatitis B e Antigen or Viral Load" 123, no. 5 (2014) Fan, Lin et al. "Cost-Effectiveness of Testing Hepatitis B–Positive Pregnant Women for Hepatitis B e Antigen or Viral Load" vol. 123, no. 5, 2014 Export RIS Citation Information.

:

Fan, Lin ;

Owusu-Edusei, Kwame

5 2014 | Obstet Gynecol. 123(5):929-937

:

OBJECTIVETo estimate the cost-effectiveness of testing pregnant women with hepatitis B (hepatitis B surface antigen [HBsAg]-positive) for hepatitis B ...
Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques

CITE Title : Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques Personal Author(s) : Choi, Youkyung;Lee, Grace Sanghee;Li, Song;Lee, Jeong Woo;Mixson-Hayden, Tonya;Woo, Jungreem;Xia, Dengning;Prausnitz, Mark R.;Kamili, Saleem;Purdy, Michael A.;Tohme, Rania A.; Published Date : 6 01 2023;6-01-; Source : Vaccine. 41(24):3663-3672 URL : https://stacks.cdc.gov/view/cdc/153512 Choi, Youkyung et al. (2023). Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques. 41(24). Choi, Youkyung et al. "Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques" 41, no. 24 (2023) Choi, Youkyung et al. "Hepatitis B vaccine delivered by microneedle patch: Immunogenicity in mice and rhesus macaques" vol. 41, no. 24, 2023 Export RIS Citation Information.

:

Choi, Youkyung ;

Lee, Grace Sanghee

6 01 2023 | Vaccine. 41(24):3663-3672

:

Vaccination against hepatitis B using a dissolving microneedle patch (dMNP) could increase access to the birth dose by reducing expertise needed for v...
Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001–2018

CITE Title : Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001–2018 Personal Author(s) : Ly, Kathleen N.;Xing, Jian;Spradling, Philip R.; Published Date : 9-01- Source : J Infect Dis. 224(5):804-812 URL : https://stacks.cdc.gov/view/cdc/153604 Ly, Kathleen N. et al. (2022). Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001–2018. 224(5). Ly, Kathleen N. and Xing, Jian and Spradling, Philip R. "Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001–2018" 224, no. 5 (2022) Ly, Kathleen N. et al. "Trends in Prevalence and Characteristics of Resolved and Current Hepatitis B Among US-Born Persons: National Health and Nutrition Examination Survey, 2001–2018" vol. 224, no. 5, 2022 Export RIS Citation Information.

:

Ly, Kathleen N. ;

Xing, Jian

9-01- | J Infect Dis. 224(5):804-812

:

Background.After decades of decline, US acute hepatitis B incidence flattened since 2011. In persons aged ≥40 years and in jurisdictions affected by...
Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18–49 Years With Risk Factors for Hepatitis B Virus Infection—United States, 2003–2014

CITE Title : Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18–49 Years With Risk Factors for Hepatitis B Virus Infection—United States, 2003–2014 Personal Author(s) : King, Hope;Xing, Jian;Dean, Hazel D.;Holtzman, Deborah; Published Date : 4 15 2020;4-15-; Source : Clin Infect Dis. 70(9):1907-1915 URL : https://stacks.cdc.gov/view/cdc/92340 King, Hope et al. (2020). Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18–49 Years With Risk Factors for Hepatitis B Virus Infection—United States, 2003–2014. 70(9). King, Hope et al. "Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18–49 Years With Risk Factors for Hepatitis B Virus Infection—United States, 2003–2014" 70, no. 9 (2020) King, Hope et al. "Trends in Prevalence of Protective Levels of Hepatitis B Surface Antibody Among Adults Aged 18–49 Years With Risk Factors for Hepatitis B Virus Infection—United States, 2003–2014" vol. 70, no. 9, 2020 Export RIS Citation Information.

:

King, Hope ;

Xing, Jian

4 15 2020 | Clin Infect Dis. 70(9):1907-1915

:

Background.Hepatitis B virus (HBV) infection can be prevented through vaccination. However, previous data show that only about 24%–45% of US adults ...
The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey

CITE Title : The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey Personal Author(s) : Kasradze, Ana;Shadaker, Shaun;Kuchuloria, Tatia;Gamkrelidze, Amiran;Nasrullah, Muazzam;Gvinjilia, Lia;Baliashvili, Davit;Chitadze, Nazibrola;Kodani, Maja;Tejada-Strop, Alexandra;Drobeniuc, Jan;Hagan, Liesl;Morgan, Juliette;Imnadze, Paata;Averhoff, Francisco; Published Date : 8 2020 Source : Public Health. 185:341-347 URL : https://stacks.cdc.gov/view/cdc/93159 Kasradze, Ana et al. (2020). The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey. 185 Kasradze, Ana et al. "The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey" 185 (2020) Kasradze, Ana et al. "The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey" vol. 185, 2020 Export RIS Citation Information.

:

Kasradze, Ana ;

Shadaker, Shaun

8 2020 | Public Health. 185:341-347

:

ObjectivesThe burden of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections is unknown in Georgia. This analysis describes the prevalence o...
Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan

CITE Title : Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan Personal Author(s) : Khetsuriani, Nino;Tishkova, Faina;Jabirov, Shamsidin;Wannemuehler, Kathleen;Kamili, Saleem;Pirova, Zulfiya;Mosina, Liudmila;Gavrilin, Eugene;Ursu, Pavel;Drobeniuc, Jan; Published Date : Jun 10 2015 Source : Vaccine. 33(32):4019-4024. URL : https://stacks.cdc.gov/view/cdc/37120 Khetsuriani, Nino et al. (2015). Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan. 33(32). Khetsuriani, Nino et al. "Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan" 33, no. 32 (2015) Khetsuriani, Nino et al. "Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan" vol. 33, no. 32, 2015 Export RIS Citation Information.

:

Khetsuriani, Nino ;

Tishkova, Faina

Jun 10 2015 | Vaccine. 33(32):4019-4024.

:

BackgroundTajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and repo...
A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination

CITE Title : A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination Personal Author(s) : Nguyen, Tran Hien;Vu, Minh Huong;Nguyen, Van Cuong;Nguyen, Lien Huong;Toda, Kohei;Nguyen, Tuyet Nga;Dao, Sang;Wannemuehler, Kathleen A.;Hennessey, Karen A.; Published Date : Nov 24 2013 Source : Vaccine. 32(2):217-222. URL : https://stacks.cdc.gov/view/cdc/37230 Nguyen, Tran Hien et al. (2013). A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination. 32(2). Nguyen, Tran Hien et al. "A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination" 32, no. 2 (2013) Nguyen, Tran Hien et al. "A reduction in chronic hepatitis B virus infection prevalence among children in Vietnam demonstrates the importance of vaccination" vol. 32, no. 2, 2013 Export RIS Citation Information.

:

Nguyen, Tran Hien ;

Vu, Minh Huong

Nov 24 2013 | Vaccine. 32(2):217-222.

:

BackgroundVietnam has high endemic hepatitis B virus infection with >8% of adults estimated to have chronic infection. Hepatitis B vaccine was first i...
Detecting Hepatitis B Surface Antigen Mutants

CITE Title : Detecting Hepatitis B Surface Antigen Mutants Personal Author(s) : Coleman, Paul F. Published Date : Feb 2006 Source : Emerg Infect Dis. 12(2):198-203. URL : https://stacks.cdc.gov/view/cdc/15818 Coleman, Paul F. (2006). Detecting Hepatitis B Surface Antigen Mutants. 12(2). Coleman, Paul F. "Detecting Hepatitis B Surface Antigen Mutants" 12, no. 2 (2006) Coleman, Paul F. "Detecting Hepatitis B Surface Antigen Mutants" vol. 12, no. 2, 2006 Export RIS Citation Information.

:

Coleman, Paul F.

Feb 2006 | Emerg Infect Dis. 12(2):198-203.

:

Hepatitis B viral mutants can emerge in patients as a result of selection pressure from either immune response or treatment options. Mutations that oc...
Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal

CITE Title : Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal Personal Author(s) : Upreti, Shyam Raj;Gurung, Santosh;Patel, Minal;Dixit, Sameer M.;Krause, L. Kendall;Shakya, Geeta;Wannemuehler, Kathleen;Rajbhandari, Rajesh;Bohara, Rajendra;Schluter, W. William; Published Date : 7 23 2014;7-23-; Source : Vaccine. 32(34):4304-4309 URL : https://stacks.cdc.gov/view/cdc/36716 Upreti, Shyam Raj et al. (2014). Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal. 32(34). Upreti, Shyam Raj et al. "Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal" 32, no. 34 (2014) Upreti, Shyam Raj et al. "Prevalence of chronic hepatitis B virus infection before and after implementation of a hepatitis B vaccination program among children in Nepal" vol. 32, no. 34, 2014 Export RIS Citation Information.

:

Upreti, Shyam Raj ;

Gurung, Santosh

7 23 2014 | Vaccine. 32(34):4304-4309

:

BackgroundIn Nepal, an estimated 2–4% of the population has chronic hepatitis B virus (HBV) infection. To combat this problem, from 2002–2004, a n...
Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants

CITE Title : Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants Personal Author(s) : Chasela, Charles S.;Kourtis, Athena P.;Wall, Patrick;Drobeniuc, Jan;King, Caroline C.;Thai, Hong;Teshale, Eyasu H.;Hosseinipour, Mina;Ellington, Sascha;Codd, Mary B.;Jamieson, Denise J.;Knight, Rod;Fitzpatrick, Patricia;Kamili, Saleem;Hoffman, Irving;Kayira, Dumbani;Mumba, Noel;Kamwendo, Deborah D.;Martinson, Francis;Powderly, William;Teo, Chong-Gee;van der Horst, Charles; Published Date : 3 2014;3-2014; Source : J Hepatol. 60(3):508-514 URL : https://stacks.cdc.gov/view/cdc/30658 Chasela, Charles S. et al. (2014). Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. 60(3). Chasela, Charles S. et al. "Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants" 60, no. 3 (2014) Chasela, Charles S. et al. "Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants" vol. 60, no. 3, 2014 Export RIS Citation Information.

:

Chasela, Charles S. ;

Kourtis, Athena P.

3 2014 | J Hepatol. 60(3):508-514

:

Background & AimsThe extent of HBV infection to infants of HBV/HIV-coinfected pregnant women in sub-Saharan Africa is unknown. The aim of this study w...
Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011–2014

CITE Title : Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011–2014 Personal Author(s) : Harris, Aaron M.;Isenhour, Cheryl;Schillie, Sarah F.;Vellozzi, Claudia; Published Date : Apr 01 2018 Source : Infect Dis Obstet Gynecol. 2018; 2018. URL : https://stacks.cdc.gov/view/cdc/56527 Harris, Aaron M. et al. (2018). Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011–2014. 2018 Harris, Aaron M. et al. "Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011–2014" 2018 (2018) Harris, Aaron M. et al. "Hepatitis B Virus Testing and Care among Pregnant Women Using Commercial Claims Data, United States, 2011–2014" vol. 2018, 2018 Export RIS Citation Information.

:

Harris, Aaron M. ;

Isenhour, Cheryl

Apr 01 2018 | Infect Dis Obstet Gynecol. 2018; 2018.

:

IntroductionPregnant women should receive hepatitis B virus (HBV) testing with hepatitis B surface antigen (HBsAg), but it is unclear whether HBV-infe...
Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen

CITE Title : Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen Personal Author(s) : Jourdain, Gonzague;Ngo-Giang-Huong, Nicole;Cressey, Tim R.;Hua, Lei;Harrison, Linda;Tierney, Camlin;Salvadori, Nicolas;Decker, Luc;Traisathit, Patrinee;Sirirungsi, Wasna;Khamduang, Woottichai;Bowonwatanuwong, Chureeratana;Puthanakit, Thanyawee;Siberry, George K.;Watts, Diane Heather;Murphy, Trudy V.;Achalapong, Jullapong;Hongsiriwon, Suchat;Klinbuayaem, Virat;Thongsawat, Satawat;Chung, Raymond T.;Pol, Stanislas;Chotivanich, Nantasak; Published Date : Aug 09 2016 Source : BMC Infect Dis. 16. URL : https://stacks.cdc.gov/view/cdc/41142 Jourdain, Gonzague et al. (2016). Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen. 16 Jourdain, Gonzague et al. "Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen" 16 (2016) Jourdain, Gonzague et al. "Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen" vol. 16, 2016 Export RIS Citation Information.

:

Jourdain, Gonzague ;

Ngo-Giang-Huong, Nicole

Aug 09 2016 | BMC Infect Dis. 16.

:

BackgroundChronic hepatitis B virus (HBV) infection is complicated by cirrhosis and liver cancer. In Thailand, 6-7 % of adults are chronically infect...
Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018

CITE Title : Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018 Personal Author(s) : Minta, Anna A.;Silva, Maria Wilda T.;Shrestha, Achyut;de Quiroz-Castro, Maricel;Tohme, Rania A.;Quimson, Mario E.;Jiz, Mario Antonio;Woodring, Joseph; Published Date : 4 01 2021 Source : Vaccine. 39(14):1982-1989 URL : https://stacks.cdc.gov/view/cdc/128974 Minta, Anna A. et al. (2021). Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018. 39(14). Minta, Anna A. et al. "Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018" 39, no. 14 (2021) Minta, Anna A. et al. "Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018" vol. 39, no. 14, 2021 Export RIS Citation Information.

:

Minta, Anna A. ;

Silva, Maria Wilda T.

4 01 2021 | Vaccine. 39(14):1982-1989

:

The World Health Organization Western Pacific Region (WPR) set a hepatitis B virus (HBV) control target to achieve HBV surface antigen (HBsAg) prevale...

1 - 20 / 50